All Programs

Use the tool below to view all available Global Neurology Academy Series

Recognizing MS: Understanding Symptoms and Avoiding Misdiagnosis
Recognizing MS: Understanding Symptoms and Avoiding Misdiagnosis
NeuroFrontiers
Recognizing MS: Understanding Symptoms and Avoiding Misdiagnosis
Epigenetic Immune Signatures in Alzheimer’s: Implications for Diagnosis and Therapy
Epigenetic Immune Signatures in Alzheimer’s: Implications for Diagnosis and Therapy
NeuroFrontiers
Epigenetic Immune Signatures in Alzheimer’s: Implications for Diagnosis and Therapy
- David Gate, PhD
Advancing MS Care: Evolving Treatments and High-Efficacy Approaches
Advancing MS Care: Evolving Treatments and High-Efficacy Approaches
NeuroFrontiers
Advancing MS Care: Evolving Treatments and High-Efficacy Approaches
- Marisa McGinley, DO
Understanding MS: Managing Hidden and Overlooked Symptoms
Understanding MS: Managing Hidden and Overlooked Symptoms
Global Neurology Academy
Understanding MS: Managing Hidden and Overlooked Symptoms
- Marisa McGinley, DO
Safety and Efficacy of Onasemnogene Abeparvovec in Pediatric SMA Across Expanded Weight Cohorts
Safety and Efficacy of Onasemnogene Abeparvovec in Pediatric SMA Across Expanded Weight Cohorts
NeuroFrontiers
Safety and Efficacy of Onasemnogene Abeparvovec in Pediatric SMA Across Expanded Weight Cohorts
ASD in Children with SMA Type I: Diagnostic Challenges in a Multifactorial Context
ASD in Children with SMA Type I: Diagnostic Challenges in a Multifactorial Context
NeuroFrontiers
ASD in Children with SMA Type I: Diagnostic Challenges in a Multifactorial Context
New-Onset Ketosis-Prone Diabetes in an Adult with Spinal Muscular Atrophy Type III
New-Onset Ketosis-Prone Diabetes in an Adult with Spinal Muscular Atrophy Type III
NeuroFrontiers
New-Onset Ketosis-Prone Diabetes in an Adult with Spinal Muscular Atrophy Type III
Early Evidence Supports Videoconference ACT for Dementia Caregivers with Depression
Early Evidence Supports Videoconference ACT for Dementia Caregivers with Depression
NeuroFrontiers
Early Evidence Supports Videoconference ACT for Dementia Caregivers with Depression
Metabolic Modulation in Alzheimer’s Disease: Early Clinical Signals from a Dapagliflozin Pilot Trial
Metabolic Modulation in Alzheimer’s Disease: Early Clinical Signals from a Dapagliflozin Pilot Trial
NeuroFrontiers
Metabolic Modulation in Alzheimer’s Disease: Early Clinical Signals from a Dapagliflozin Pilot Trial
Redefining Migraine Care: Early Diagnosis and Prevention Strategies
Redefining Migraine Care: Early Diagnosis and Prevention Strategies
NeuroFrontiers
Redefining Migraine Care: Early Diagnosis and Prevention Strategies
- Charles Turck, PharmD, BCPS, BCCCP
- Stephanie Nahas, MD
Early Ocrelizumab Intervention in RRMS: Real-World Data Reinforces a Shift in Strategy
Early Ocrelizumab Intervention in RRMS: Real-World Data Reinforces a Shift in Strategy
NeuroFrontiers
Early Ocrelizumab Intervention in RRMS: Real-World Data Reinforces a Shift in Strategy
Intermittent Calorie Restriction Alters Immune and Metabolic Markers in RRMS
Intermittent Calorie Restriction Alters Immune and Metabolic Markers in RRMS
NeuroFrontiers
Intermittent Calorie Restriction Alters Immune and Metabolic Markers in RRMS
Data Equity in Action: Largest Real-World MS Analysis Confirms Fumarate Efficacy Across Racial Groups
Data Equity in Action: Largest Real-World MS Analysis Confirms Fumarate Efficacy Across Racial Groups
NeuroFrontiers
Data Equity in Action: Largest Real-World MS Analysis Confirms Fumarate Efficacy Across Racial Groups
Exploring Circulating CD34+ Cells as a Biomarker of Fracture Risk in DMD
Exploring Circulating CD34+ Cells as a Biomarker of Fracture Risk in DMD
NeuroFrontiers
Exploring Circulating CD34+ Cells as a Biomarker of Fracture Risk in DMD
Treatment of a Broader Population of Patients With DMD
Treatment of a Broader Population of Patients With DMD
CME/CE
Treatment of a Broader Population of Patients With DMD
1.00 credit
- Crystal Proud, MD
- Erika Finanger, MD, MS
1.00 credit
Managing Migraine: Inadequate Responses and Treatment Transitions
Managing Migraine: Inadequate Responses and Treatment Transitions
NeuroFrontiers
Managing Migraine: Inadequate Responses and Treatment Transitions
- Charles Turck, PharmD, BCPS, BCCCP
- Vincent Martin, MD, FACP, FAHS

All Programs

Popular

NEED HELP?

Contact us

NEED HELP?

Contact us

All Programs

Popular

Title

Share on ReachMD